Science Desk · NIST · RaDAR program
NIST maps how toxic adulterants in fentanyl vary by region and over time
The study analyzed 4,563 drug-residue samples collected nationwide from January 2024 through June 2026.
Agency release dated 2026-10-08

What the record says
- NIST chemist Edward Sisco and colleagues reported the findings in the journal Drug Testing and Analysis.
- The analysis covered 4,563 samples of drug residues collected nationwide between January 2024 and June 2026.
- NIST notes most of the adulterants are not opioids and need additional medical treatment; xylazine can cause wounds severe enough to require amputation if untreated.
- The work is part of NIST’s Rapid Drug Analysis and Research (RaDAR) program.
Source: NIST — NIST Study Shows How the Toxic Substances Mixed Into Fentanyl Vary Across the U.S. and Change Over Time. Notice Nearby summarized this release; it adds no claims beyond the agency record.